Constipation, a common gastrointestinal disorder, often presents a diagnostic and therapeutic challenge. This article aims to elucidate a comprehensive approach to its diagnosis and treatment, enabling physicians to effectively manage this condition.
Diagnosis primarily relies on patients' symptoms, with Rome IV criteria being the standard. However, it's crucial to consider differential diagnoses, including irritable bowel syndrome and opioid-induced constipation. A thorough medical history, physical examination, and, if necessary, additional diagnostic tests such as colonoscopy or transit studies can help rule out secondary causes.
First-line treatment typically involves lifestyle modifications and over-the-counter remedies. Dietary changes, such as increasing fiber and fluid intake, can significantly improve symptoms. Osmotic laxatives are often effective, while stimulant laxatives are reserved for short-term use.
For patients unresponsive to first-line treatment, second-line options include prescription drugs such as lubiprostone, linaclotide, and plecanatide. These agents work by increasing intestinal fluid secretion and accelerating transit, thereby alleviating constipation. However, they may cause side effects like diarrhea and abdominal pain.
In refractory cases, biofeedback therapy or surgical intervention may be considered. Biofeedback is particularly beneficial for patients with dyssynergic defecation. Surgery, while rarely used, is an option for severe cases of slow-transit constipation or rectal prolapse.
Understanding constipation's complexity and adopting a comprehensive approach to its diagnosis and treatment is essential for effective patient management. By tailoring the approach to individual patient needs, physicians can significantly improve their patients' quality of life and reduce the burden of this common condition.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation